The pathophysiology and pathology of SARS-CoV-2 infection
DOI:
https://doi.org/10.18203/2320-6012.ijrms20234029Keywords:
SARS-CoV-2, Angiotensin II, ACE2, AIDS-associated nephropathy, InflammationAbstract
SARS-CoV-2 infection is a major pandemic that has involved all continents in the world. It has caused almost seven million deaths since its onset. SARS-CoV-2 commonly enters cells by binding to angiotensin-converting enzyme 2 (ACE2) molecules on the surface of cells in the human body. SARS-CoV-2 infection, although mild in many patients, has the potential to cause dysfunction of many organ systems in the body. The body response to the internalisation of the virus in the epithelial cells of the lungs can lead to alveolar epithelial inflammation, commonly referred to as the exudative phase of acute respiratory distress syndrome (ARDS). Cardiac symptoms shown by patients infected with SARS-CoV-2 include chest tightness/pain and palpitations. These features can be because of newly developed or worsening ischaemic heart disease and arrythmias, respectively. SARS-CoV-2 infection is known to cause a clinical condition known as COVID-19-associated nephropathy (COVAN), a disease quite similar to HIV-associated nephropathy (HIVAN). Like HIVAN, COVAN is relatively more common in people of African descent and is associated with the APOL1 variant gene. Researchers have not identified unique morphological changes that could be used to identify the infection in tissues. Hence, the use of RT-PCR for diagnosis is still very important.
Metrics
References
Johns Hopkins Coronavirus Resource Center. COVID-19 Map. Available at: https://coronavirus.jhu.edu/map.html. Accessed on 2 August, 2023.
Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020;323(23):2427-9.
Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-7.
Ahn JH, Kim J, Hong SP, Choi SY, Yang MJ, Ju YS et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest. 2021;131(13).
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020;202(5):756-9.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
Jakubec P, Fišerová K, Genzor S, Kolář M. Pulmonary Complications after COVID-19. Life (Basel). 2022;12(3):357.
Cîrjaliu RE, Deacu M, Gherghișan I, Marghescu A Ștefania, Enciu M, Băltățescu GI et al. Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis. Biomedicines. 2023;11(6):1739.
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respiratory Med. 2021;9(7):747-54.
Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328-37.
Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang Xet al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020;296(2):E55-64.
De Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M et al. Severity and mortality of COVID-19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metabol Syndrome. 2020;12(1):75.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41.
Gupta A, Nayan N, Nair R, Kumar K, Joshi A, Sharma S et al. Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irrespective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India. SN Compr Clin Med. 2021;3(4):937-44.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60.
Patel SV, Shah S, Patel R, Bavishi S, Pethani Y, Shah K. Ovarian Vein Thrombosis: A Sequela of COVID-Associated Coagulopathy. Cureus. 2023;15(3):e36437.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133(9):1025-31.
Cao J, Hu X, Cheng W, Yu L, Tu WJ, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med. 2020;46(5):851-3.
Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36(1):78-80.
Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, Wu CL et al. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest. 2004;126(2):509-17.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
Group BMJP. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1295.
Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780.
Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R et al. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int. 2020;14(5):711-22.
Paliogiannis P, Zinellu A. Bilirubin levels in patients with mild and severe COVID-19: A pooled analysis. Liver Int. 2020;40(7):1787-8.
Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut. 2021;70(4):807-9.
Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52(4):584-99.
Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Alimentary Pharmacol Therape. 2020;52(2):267-75.
Von Stillfried S, Boor P. Detection methods for SARS-CoV-2 in tissue. Pathologe. 2021;42(1):81-8.
Volbeda M, Jou-Valencia D, van den Heuvel MC, Zijlstra JG, Franssen CFM, van der Voort PHJ et al. Acute and chronic histopathological findings in renal biopsies in COVID-19. Clin Exp Med. 2022;1-12.
Dhillon VS, Alkashash A, Viquez-Beita K. Coronavirus disease 2019-associated nephropathy in an African American patient: a case report and review of the literature. J Med Case Rep. 2023;17(1):153.
Vishwajeet V, Krishna H, Ghatak S, Elhence PA, Ambwani S, Varthya SB. Renal Histopathological Changes in Coronavirus Disease 2019 Patients: A Systematic Review and Meta-analysis of Individual Patient Data. Saudi J Kidney Dis Transpl. 2021;32(6):1523-44.
Mahjani M, Parvin M, Ghobadi S, Jafari A, Ahangar H, Gohari S et al. Postmortem Histopathologic Findings and SARS-CoV-2 Detection in Autopsy Kidneys of Patients With COVID-19: A Systematic Review and Meta-Analysis. Am J Clin Pathol. 2023;159(5):429-36.
Santoriello D, Khairallah P, Bomback AS, Xu K, Kudose S, Batal I et al. Postmortem Kidney Pathology Findings in Patients with COVID-19. J Am Soc Nephrol. 2020;31(9):2158-67.
Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198-209.
Guven G, Ince C, Topeli A, Caliskan K. Cardio-Pulmonary-Renal Consequences of Severe COVID-19. Cardiorenal Med. 2021;11(3):133-9.
Fontana F, Cazzato S, Giovanella S, Ballestri M, Leonelli M, Mori G et al. Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19. Kidney Int Rep. 2020;5(10):1815-22.
Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S et al. AKI in Hospitalized Patients with COVID-19. J Am Society Nephrol. 2021;32(1):151.
Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193-9.
Batlle D, Jose Soler M, Ye M. ACE2 and Diabetes: ACE of ACEs? Diabetes. 2010;59(12):2994-6.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.
Deigendesch N, Sironi L, Kutza M, Wischnewski S, Fuchs V, Hench J et al. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathol. 2020;140(4):583-6.
Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P et al. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol. 2021;31(6):e13013.
Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H et al. Microvascular Injury in the Brains of Patients with COVID-19. N Engl J Med. 2021;384(5):481-3.
Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145(7):2555-68.
Gutierrez Amezcua JM, Jain R, Kleinman G, Muh CR, Guzzetta M, Folkerth R et al. COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms. SN Compr Clin Med. 2020;2(11):2109-25.
Um A, Aa A, Jm E, Ew W, Rs R, Sa H et al. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiological genomics. 2021;53(2).
Xia H, Sriramula S, Chhabra KH, Lazartigues E. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res. 2013;113(9):108-96.
Tikellis C, Thomas MC. Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. Int J Pept. 2012;2012:256294.
Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, Edler C et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919-29.
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-5.
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8.
Fabbri VP, Foschini MP, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C et al. Brain ischemic injury in COVID‐19‐infected patients: a series of 10 post‐mortem cases. Brain Pathol. 2020;31(1):205-10.
Timmons GM, Rempe T, Bevins EA, Goodwill V, Miner A, Kavanaugh A et al. CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection. Neurol Neuroimmunol Neuroinflamm. 2021;8(5):e1048.
Ismail II, Salama S. Association of CNS demyelination and COVID-19 infection: an updated systematic review. J Neurol. 2022;269(2):541-76.
Downloads
Published
How to Cite
Issue
Section
